BioKorf Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $50K
Latest Deal Amount
  • Investors
  • 3

BioKorf General Information

Description

Developer of prefabricated drug dosages intended for next-generation biopharmaceuticals. The company offers a flexible and integrated arrangement of prefabricated working parts assembled as a drug delivery system that provides patient-centered medicine and ensures better recovery, enabling healthcare professionals to provide multiple dosage form types into one unique form.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Primary Office
  • 1008 Ravinia Road
  • West Lafayette, IN 47906
  • United States
+1 (765) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioKorf Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 31-Jul-2015 $50K 0000 Completed Startup
2. Early Stage VC 19-May-2015 0000 0000 Completed Startup
1. Accelerator/Incubator 07-Oct-2014 Completed Startup
To view BioKorf’s complete valuation and funding history, request access »

BioKorf Executive Team (3)

Name Title Board Seat Contact Info
Andrew Otte Ph.D Co-Founder & Chief Executive Officer
Teresa Carvajal Chief Operating Officer
Rodolfo Pinal Co-Founder & Chief Scientific Officer
To view BioKorf’s complete executive team members history, request access »

BioKorf Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government 000 0000 000000 0
Elevate Ventures Venture Capital Minority 000 0000 000000 0
Purdue Research Foundation Limited Partner 000 0000 000000 0
To view BioKorf’s complete investors history, request access »